2012 Progress and Controversies in Gynecologic Oncology Conference

Meeting Overview

On behalf of the Scientific Community, we are pleased to invite you to the 2012 Progress and Controversies in Gynecologic Oncology Conference, to be held in Barcelona, Spain, on 13–14 April 2012.

This meeting will serve as a valuable forum for the presentation and discussion of newly available data across various gynecologic malignancies including ovarian, cervical, and endometrial cancers. Participants will be provided with updates on practice-changing data in a practical and interactive format, fostering discussion, and impacting clinical outcomes for patients.

Scientific Committee

    • Andreas du Bois, MD, PhD
      Klinikum Essen Mitte
      Essen, Germany
    • Nicoletta Colombo, MD
      University of Milan – Bicocca
      and the European Institute of Oncology

      Milan, Italy
    • Peter Harper, MD, FRCP
      Guy's and St Thomas' Hospital
      London, United Kingdom
    • Stanley B. Kaye, MD
      The Royal Marsden Hospital
      Sutton, United Kingdom
    • Andrés Poveda, MD
      Fundacion Instituto Valenciano de Oncologia
      Valencia, Spain
    • Bradley J. Monk, MD, FACS, FACOG
      Creighton University School of Medicine
      at St Joseph's Hospital and Medical Center
      Phoenix, Arizona, United States
    • Eric Pujade-Lauraine, MD, PhD
      Centre Hospitalier Universitaire Hôtel-Dieu
      Paris, France
    • Ignace Vergote, MD, PhD
      University Hospital Gasthuisberg
      Leuven, Belgium

Target Audience

The 2012 Progress and Controversies in Gynecologic Oncology Conference, is intended for gynecologists, oncologists, radiation therapists, surgeons, pathologists, and other practitioners including allied health professionals involved in the diagnosis and management of gynecologic malignancies.

Learning Objectives

After successful completion of this educational activity, participants should be able to:

  • Develop a practical approach to cervical cancer staging and disease management
  • Discuss the role of radiotherapy and systemic therapies in the management of endometrial cancer
  • Derive the optimal surgical management of ovarian cancer based on disease stage and clinical presentation
  • Assess standard and emerging therapeutic options for ovarian cancer and discuss their impact on patient outcomes

Faculty

Scientific Committee

Andreas du Bois, MD, PhD
Klinikum Essen Mitte
Essen, Germany

Nicoletta Colombo, MD
University of Milan-Bicocca
European Institute of Oncology
Milan, Italy

Peter G. Harper, MD, FRCP
Guy's and St Thomas' Hospital
London, United Kingdom

Stanley B. Kaye, MD
The Royal Marsden Hospital
Sutton, United Kingdom

Bradley J. Monk, MD, FACS, FACOG
Creighton University School of Medicine at
St Joseph's Hospital and Medical Center
Phoenix, Arizona, United States

Andrés Poveda, MD
Fundacion Instituto Valenciano de Oncologia
Valencia, Spain

Eric Pujade-Lauraine, MD, PhD
Centre Hospitalier Universitaire Hotel-Dieu
Paris, France

Ignace Vergote, MD, PhD
University Hospital Gasthuisberg
Leuven, European Union


Faculty
Giovanni Aletti, MD
European Institute of Oncology
Milan,Italy

Christian Marth, MD, PhD
Innsbruck University Hospital
Innsbruck,Austria

Antonio González Martín, MD
M. D. Anderson Cancer Center
Madrid, Spain

Sandro Pignata, MD, PhD
National Cancer Institute
Naples, Italy

Philipp Harter, MD
Klinikum Essen Mitte
Essen, Germany

Jaime Prat, MD, FRCPath
Hospital de la Santa Creu I Sant Pau
Barcelona, Spain

Christhardt Köhler, MD
Charité University Hospital
Berlin, Germany

Isabelle Ray-Coquard, MD, PhD
Centre Léon Bérard
Lyon, France

Sean Kehoe, MD, FRCOG
Oxford Radcliffe Hospital
Oxford, United Kingdom

Gillian Thomas, MD
Sunnybrook Odette Cancer Center
Toronto, Ontario, Canada

Angelo Maggioni, MD
European Institute of Oncology
Milan, Italy

Ate G.J. van der Zee, MD, PhD
University Medical Center Groningen
Groningen, the Netherlands

Agenda

Friday, 13 April 2012
13.00 Welcome and introduction
Session I: Cervical Cancer and Vulvar Cancer
13.10 Interactive clinical case: Locally advanced cervical cancer
13.40 Expert Opinion/Debate:
Is there a role for surgical staging in operable cervical cancer?
14.30 Update on cytotoxic and targeted therapies for cervical cancer
14.55 Updates in the treatment of vulvar cancer
15.20 Break
Session II: Endometrial Cancer and Beyond
15.50 What is the role of robotic surgery in gynecologic cancer?
16.15 Expert Opinion/Debate:
There are still indications for lymphadenectomy in endometrial cancer
17.05 Interactive Clinical Case:
Stage IB grade 3 endometriod endometrial cancer
17.35 Update on advanced/recurrent endometrial cancer management: Considering new agents
18.00 Concluding remarks: Day 1
18.15 Adjourn
Saturday, 14 April 2012
8.45 Welcome and introduction
 
Session III: Ovarian Neoplasm I: First-Line Therapy
8.50 The new concepts of the biology of ovarian cancer
9.20 The role of radical surgery in advanced ovarian cancer
9.50 Interactive Clinical Case:
First-line therapy for advanced ovarian cancer
10.20 Break
Session IV: Ovarian Neoplasm II: Novel Emerging Therapies
11.00 Antiangiogenesis
11.30 Beyond antiangiogenesis
12.00 Lunch symposium
Session V: Ovarian Neoplasm II: Recurrence
13.45 Surgery for recurrent ovarian cancer
14.10 Interactive Clinical Case:
Platinum-resistant disease
14.40 Interactive Clinical Case:
Relapse at 6-12 months
15.10 Interactive Clinical Case:
Platinum-sensitive disease
15.40 Brief reports on hot topics in ovarian cancer:
  1. Low-grade serous carcinomas
  2. Clear cell carcinomas
  3. Mucinous carcinomas
16.20 Concluding remarks
16.30 Adjourn

Registration

FEE FOR ACTIVITY AND REGISTRATION
Physician early registration: €250.00
Physician regular registration: €350.00
Physician onsite registration: €450.00

Nurses / Fellows early registration: €100.00*
Nurses / Fellows regular registration: €150.00*
Nurses / Fellows onsite registration: €200.00*

Registration fees include VAT.

*Supporting documentation of eligibility may be required.

REGISTRATION DEADLINES
Early registration rate: 5 March 2012
Regular registration rate: 9 April 2012

TO REGISTER
You may register online by 9 April 2012 at www.prIMEoncology.org/gyncongress2012. Registration confirmations will be issued upon successful registration and reminders will be issued before the meeting. To preregister, registration and payment must be received no later than 5 March 2012 (early registration rate) or 9 April 2012 (regular registration rate). Please register onsite after 9 April 2012.

GROUP REGISTRATIONS
Group registration will be accepted. Further information will be available upon inquiry at
gyncongress2012@prIMEoncology.org

CANCELLATION
To receive a refund of registration fees, written notice of cancellation must be received at gyncongress2012@prIMEoncology.org.

The following deadlines and cancellation fees will apply:

  • Before 10 March 2012, a €75 administrative charge
  • From 10 March 2012, a 50% cancellation fee applies on registration fee(s)
  • From 1 April 2012, a 100% cancellation fee applies on registration fee(s)

The amount of registration fees remitted will be refunded after the Congress. Substitutions are accepted with written notification. No refunds will be made if notice is received after 31 March 2012.

prIME Oncology does not accept responsibility for reimbursement of travel, accommodation, or any other costs incurred by registrants in the rare event that this meeting should be canceled for any reason. Every effort will be made to give reasonable notice in the event of cancellation. The event agenda is subject to change without notice.

Contact

All inquiries related to the 2012 Progress and Controversies in Gynecologic Oncology Conference may be addressed to gyncongress2012@prIMEoncology.org




EU OFFICE

Scheveningseweg 58
2517 KW The Hague
the Netherlands

Tel.: + 31 70 3067190
Fax: + 31 70 3318335
Email: info@prIMEoncology.org
Web: www.prIMEoncology.org

HOTEL ACCOMMODATION
Fira Palace Barcelona
Avenida Rius i Taulet, 1-3
Barcelona, Spain
+34 934 262 223

Check in time: 15.00 hours
Check out time: 12.00 hours


The room block at Hotel Fira Palace is sold out, however you may be able to book rooms directly at www.fira-palace.com or Tel: +34 93 426 2223.

Alternatively, you can e-mail the congress secretariat at gyncongress2012@prIMEoncology.org to request a list of hotels in the nearby area of the congress venue.

CANCELLATION FEE HOTEL ROOMS
A cancellation fee may apply in the event the delegate will cancel his/her (registration and) hotel accommodation. A written notice of cancellation must be received at gyncongress2012@prIMEoncology.org.

- From 5 March 2012 the cancellation fee will be 50% of the room rate of the entire stay
- From 22 March 2012 the cancellation fee will be 100% of the room rate of the entire stay

The amount of hotel room fees remitted will be refunded after the Congress. Substitutions are accepted with written notification. In case of no-shows a 100% cancellation fee of the entire stay will apply.
ENTRY REQUIREMENTS
Most EU citizens only need their national identity card or passport to enter Spain. Non-EU citizens require a valid passport to enter Spain, but many countries are exempt from tourist visas. It is essential that you check with the Spanish embassy or consulate in your country before travelling. Without exception, passports must be valid for at least six months after your planned date of departure from Spain.

prIME Oncology will not directly contact embassies and consulates on behalf of applicants. It is the sole responsibility of the delegates to look after their visa requirements.

Note: Passport and visa requirements are liable to change at short notice. Travelers are advised to check their entry requirements with their embassy or consulate.

INVITATION LETTER
Click here to print your personalized invitation letter for the Congress. The sole purpose of this letter is to facilitate the delegates' travel visa arrangements and does not imply the provision of any financial or other support by the organizers. All expenses incurred in relation to the congress are the sole responsibility of the delegate.

BOOKING FLIGHTS
ATP Online is the online booking tool from our preferred travel partner. This online service is offered specifically for all participants of the Melanoma Conference 2012. You can book your flights directly and securely through this online service. The whole process takes only a few steps, saving you time.

To make your reservation, please click here and enter username and password in the "Login" area. This will take you into an online booking platform that will automatically show all available flights and best available fares.

Login
Username: prime/oncology
Password: prime

Please note that the costs for online bookings are € 17,50 handling cost per flight ticket. prIME does not recommend to book a car or hotel trough ATP Online as it is not possible to cancel your reservation.

GETTING THERE
From Barcelona's main International airport 'El Prat' you can travel different ways to the congress venue:
TAXI: Barcelona has 11,500 taxis easy to identify by their yellow and black color. It takes 15/20 minutes, depending on traffic.

AEROBUS: This special service is clearly signposted at the stops outside the terminal and it takes you to different parts of the city, the Plaza de España stop is the closest to the hotel, 5 minutes walk approximately.

TRAIN: The station is located to the West of the terminal. Trains go to "Sants" Station. From here you can take either the Metro - 2 stops to Plaza de España and then 10/15 minutes walk-or by taxi.

CAR: Take the Castelldefels Motorway (C-31) towards Barcelona up to Plaza de España. Turn right into Avenida Maria Cristina and drive up until you see the National Palace. Turn left into Avenida Rius i Taulet and carry on straight until Lleida Street. The hotel is right on the corner.

LOCAL TRANSPORT
Barcelona has a very good public transport system (TMB), with special ten-trip and one-day, two-day, and three-day tickets available for bus, metro, and local trains. You can call a taxi or flag them down in the streets. In many taxis you can also pay by credit card.

CLIMATE
Barcelona has a Mediterranean climate with mild, sunny winters, warm summers, and relatively low rainfall. In April the average temperatures are at 16° Celsius (61° Fahrenheit).

TIME ZONE
Barcelona is in the Central European time zone (GMT +1).

LANGUAGE
Spanish and Catalan are the two main languages spoken in Barcelona. English is also widely spoken and to some extent French and German.

CURRENCY
The Spanish currency is the Euro €.

TAXES
Value-added tax, or VAT, is otherwise known as IVA (impuesto sobre el valor añadido). IVA is 7% on accommodation and restaurant prices and is usually, but not always, included in quoted prices. On retail goods the IVA is 16%. IVA-free shopping is available in duty-free shops at all airports for people travelling between EU countries.

TIPPING
Tips are already included in restaurant bills, but it is customary to round up an extra 5-10% if you are satisfied with the service. Porters are generally tipped 1€ per bag.
The Accreditation Council on Oncology in Europe (ACOE) is a multidisciplinary body of full time specialists practising in the field of oncology and all recognised for their experience in education and expertise in their field. ACOE acknowledges the quality of the scientific programme and its educational value.

The ACOE accreditation label provides delegates with a guarantee of a high quality and unbiased educational activity. ACOE accredited events are awarded an agreed number of CME credit points (1 CME credit per educational hour), with a maximum of 6 credits per day. ACOE works in conjunction with the European Accreditation Council for Continuing Medical Education (EACCME®) operating under the umbrella of the European Union of Medical Specialists (UEMS). EACCME ® acts as a clearinghouse, facilitating the accreditation endorsement by the national CME regulatory bodies.


2012 Progress and Controversies in Gynecologic Oncology Conference
is accredited by the European Accreditation Council for Continuing Medical Education (EACCME ®) to provide the following CME activity for medical specialists. The EACCME® is an institution of the European Union of Medical Specialists (UEMS), www.uems.net. 2012 Progress and Controversies in Gynecologic Oncology Conference has been designated a maximum of 9 hours of European CME credits (ECMECs). The Congress operates an honour system implying that each medical specialist is expected to claim only those hours of credit that he/she actually spent at the Congress (with a maximum of 6 credits per day, 3 for a half day).

CME credits gained through participation at 2012 Progress and Controversies in Gynecologic Oncology Conference are recognised by most of the national CME authorities in Europe, which have agreed to cooperate in this European system. More information on the recognition of European credits in the European Countries, please refer to the ACOE website: www.acoe.be (select ‘CME credits recognition’).Through a mutual agreement between the UEMS and the American Medical Association (AMA), the European CME credits are also recognised towards the Physician’s Recognition Award (PRA). To convert European CME credits to AMA PRA Category 1 Credits please contact AMA at: www.ama-assn.org.


ACOE

UEMS


The 2012 Progress and controversies in gynecologic oncology conference has been awarded the ESMO label and 10 ESMO-MORA category 1 points. Participants will receive a certificate of attendance at the end of the meeting.


ESMO

PRINTED MATERIALS

2012 Progress and Controversies in Gynecologic Oncology Conference

Date And Location

Friday, 13 April 2012
13.30 - 16.30

Hotel Fira Palace
Avenida Rius i Taulet, 1-3
Barcelona, Spain

Organizer

This meeting is a prIME Oncology activity.

prIME Oncology

Support

Support for this educational activity is provided by F. Hoffmann-La Roche Ltd.; Boehringer Ingelheim Pharmaceuticals, Inc; Endocyte; Eisai Inc; Morphotek; Pharma Mar; and Fresenius Biotech.

Roche

Boehringer Ingelheim

Endocyte

Eisai

Morphotek

Pharma Mar

Fresenius Biotech

CONTINUING EDUCATION

The Accreditation Council on Oncology in Europe (ACOE) is a multidisciplinary body of full time specialists practising in the field of oncology and all recognised for their experience in education and expertise in their field. ACOE acknowledges the quality of the scientific programme and its educational value.

The ACOE accreditation label provides delegates with a guarantee of a high quality and unbiased educational activity. ACOE accredited events are awarded an agreed number of CME credit points (1 CME credit per educational hour), with a maximum of 6 credits per day. ACOE works in conjunction with the European Accreditation Council for Continuing Medical Education (EACCME®) operating under the umbrella of the European Union of Medical Specialists (UEMS). EACCME ® acts as a clearinghouse, facilitating the accreditation endorsement by the national CME regulatory bodies.


2012 Progress and Controversies in Gynecologic Oncology Conference
is accredited by the European Accreditation Council for Continuing Medical Education (EACCME ®) to provide the following CME activity for medical specialists. The EACCME® is an institution of the European Union of Medical Specialists (UEMS), www.uems.net. 2012 Progress and Controversies in Gynecologic Oncology Conference has been designated a maximum of 9 hours of European CME credits (ECMECs). The Congress operates an honour system implying that each medical specialist is expected to claim only those hours of credit that he/she actually spent at the Congress (with a maximum of 6 credits per day, 3 for a half day).

CME credits gained through participation at 2012 Progress and Controversies in Gynecologic Oncology Conference are recognised by most of the national CME authorities in Europe, which have agreed to cooperate in this European system. More information on the recognition of European credits in the European Countries, please refer to the ACOE website: www.acoe.be (select ‘CME credits recognition’).Through a mutual agreement between the UEMS and the American Medical Association (AMA), the European CME credits are also recognised towards the Physician’s Recognition Award (PRA). To convert European CME credits to AMA PRA Category 1 Credits please contact AMA at: www.ama-assn.org.


ACOE

UEMS


The 2012 Progress and controversies in gynecologic oncology conference has been awarded the ESMO label and 10 ESMO-MORA category 1 points. Participants will receive a certificate of attendance at the end of the meeting.


ESMO

Continuing Education

Continue